NCT01336933 2023-09-22
Combination Chemotherapy and Pralatrexate as First-Line Therapy in Treating Patients With Non-Hodgkin Lymphoma
University of Nebraska
Phase 2 Completed
University of Nebraska
National Institutes of Health Clinical Center (CC)
Eisai Inc.
Acrotech Biopharma Inc.
Chipscreen Biosciences, Ltd.
M.D. Anderson Cancer Center